VISCHER AG advises Bachem Holding on the offering. Bachem Holding AG (SIX: BANB) has successfully raised CHF 108.1 million through the placement of 1’250’000 new registered...
Bachem’s CHF 108.1 Million Accelerated Bookbuilding Process
BioVersys’ Extension of its Series C Financing Round
VISCHER AG advised AMR Action Fund. Homburger advised BioVersys AG. The AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing...
Sunrise’s Acquisition of EBL’s Telecom Division
VISCHER advised EBL on the deal. Swiss full-service provider Sunrise has signed an agreement to acquire the telecom business of utility firm EBL. EBL has been...
Anaveon’s CHF 110 Million Series B Financing Round
VISCHER advised Anaveon on the deal. Anaveon AG, a Swiss clinical-stage immuno-oncology company, has agreed to a CHF 110m Series B financing led by incoming investor...
Vifor Pharma’s CHF 20 Million Acquisition of Inositec
Kellerhals Carrard advised Vifor Pharma on the transaction. Vischer advised Inositec on the deal. Vifor Pharma acquired the Swiss firm Inositec AG, a clinical stage biopharmaceutical company...
MiniNaviDent’s Cooperation Agreement With Straumann
Vischer advised MiniNaviDent AG in the transaction. MiniNaviDent has received an investment by Straumann Holding AG to further develop and market its DENACAM system, a miniaturized...
Bachem’s CHF 583.5 Million Capital Increase
VISCHER AG advised Bachem Holding on the deal. Bachem Holding AG (SIX:BANB) has raised CHF 583.5m through an accelerated bookbuilding process by issuing 750,000 new shares...